Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10227075rdf:typepubmed:Citationlld:pubmed
pubmed-article:10227075lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10227075lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:10227075lifeskim:mentionsumls-concept:C0015726lld:lifeskim
pubmed-article:10227075lifeskim:mentionsumls-concept:C0009647lld:lifeskim
pubmed-article:10227075lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:10227075lifeskim:mentionsumls-concept:C0016701lld:lifeskim
pubmed-article:10227075lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:10227075lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:10227075pubmed:issue1lld:pubmed
pubmed-article:10227075pubmed:dateCreated1999-7-2lld:pubmed
pubmed-article:10227075pubmed:abstractTextAntidepressant drugs are effective in anxiety states, including panic disorder. Both clinical and animal studies indicate that l-sulpiride, at low, non-neuroleptic doses, has antidepressant activity. The present study examined the effect of an antidepressant dose of l-sulpiride (4 mg/kg per day SC), compared with a well-established antidepressant drug (fluoxetine, 3 mg/kg per day SC), in a rat model of anticipatory anxiety/panic behavior: conditioned fear stress-induced freezing behavior. Long-term (26 days) administration of l-sulpiride almost completely abolished freezing, a similar effect being produced by fluoxetine (freezing duration, in seconds: controls, 148.1 +/- 29.6; l-sulpiride, 27.5 +/- 8.3; fluoxetine, 72.0 +/- 15.2). The same doses of l-sulpiride (4 mg/kg SC) and fluoxetine (3 mg/kg SC) had no effect when administered for shorter periods (1, 5, or 12 days). No effect was produced by the long-term (26 days) administration of a neuroleptic dose of l-sulpiride (20 mg/kg per day SC). These results demonstrate that long-term administration of low, non-neuroleptic doses of l-sulpiride, is highly effective in an animal model of anticipatory anxiety/panic behavior.lld:pubmed
pubmed-article:10227075pubmed:languageenglld:pubmed
pubmed-article:10227075pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10227075pubmed:citationSubsetIMlld:pubmed
pubmed-article:10227075pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10227075pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10227075pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10227075pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10227075pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10227075pubmed:statusMEDLINElld:pubmed
pubmed-article:10227075pubmed:monthMarlld:pubmed
pubmed-article:10227075pubmed:issn0033-3158lld:pubmed
pubmed-article:10227075pubmed:authorpubmed-author:BertoliniAAlld:pubmed
pubmed-article:10227075pubmed:authorpubmed-author:PoggioliRRlld:pubmed
pubmed-article:10227075pubmed:authorpubmed-author:ForgioneAAlld:pubmed
pubmed-article:10227075pubmed:authorpubmed-author:VergoniA VAVlld:pubmed
pubmed-article:10227075pubmed:authorpubmed-author:BenelliAAlld:pubmed
pubmed-article:10227075pubmed:authorpubmed-author:ArlettiRRlld:pubmed
pubmed-article:10227075pubmed:authorpubmed-author:CavazzutiEElld:pubmed
pubmed-article:10227075pubmed:issnTypePrintlld:pubmed
pubmed-article:10227075pubmed:volume143lld:pubmed
pubmed-article:10227075pubmed:ownerNLMlld:pubmed
pubmed-article:10227075pubmed:authorsCompleteYlld:pubmed
pubmed-article:10227075pubmed:pagination20-3lld:pubmed
pubmed-article:10227075pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:meshHeadingpubmed-meshheading:10227075...lld:pubmed
pubmed-article:10227075pubmed:year1999lld:pubmed
pubmed-article:10227075pubmed:articleTitlel-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats.lld:pubmed
pubmed-article:10227075pubmed:affiliationDepartment of Biomedical Sciences, Section of Pharmacology, University of Modena, Italy. farmacol@unimo.itlld:pubmed
pubmed-article:10227075pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10227075lld:pubmed